Cancers develop in a complex mutational landscape. Genetic models of tumor formation have been used to explore how combinations of mutations cooperate to promote tumor formation in vivo. Here, we identify lactate dehydrogenase (LDH), a key enzyme in Warburg effect metabolism, as a cooperating factor that is both necessary and sufficient for epidermal growth factor receptor (EGFR)-driven epithelial neoplasia and metastasis in a Drosophila model. LDH is upregulated during the transition from hyperplasia to neoplasia, and neoplasia is prevented by LDH depletion. Elevated LDH is sufficient to drive this transition. Notably, genetic alterations that increase glucose flux, or a high-sugar diet, are also sufficient to promote EGFR-driven neoplasia, and this depends on LDH activity. We provide evidence that increased LDHA expression promotes a transformed phenotype in a human primary breast cell culture model. Furthermore, analysis of publically available cancer data showed evidence of synergy between elevated EGFR and LDHA activity linked to poor clinical outcome in a number of human cancers. Altered metabolism has generally been assumed to be an enabling feature that accelerates cancer cell proliferation. Our findings provide evidence that sugar metabolism may have a more profound role in driving neoplasia than previously appreciated.
In Brief
Eichenlaub et al. examine gene expression changes during the transition from hyperplasia to neoplasia and identify lactate dehydrogenase as a key driver of neoplasia in a Drosophila EGFR model. Elevated sugar flux or a high-sugar diet also drive neoplasia. Synergy between EGFR and LDHA correlates with poor clinical outcome in some human cancers.
INTRODUCTION
Cancers develop in a complex mutational landscape [1] . Individual tumors carry hundreds, even thousands, of mutations. Specific tumor types have identifiable signatures, consisting of a small number of relatively common ''driver'' mutations [2] . The mutational spectrum can vary in different regions of any given tumor, indicating clonal heterogeneity [3, 4] . This heterogeneity poses a challenge to identify which among the many mutational changes contribute to disease.
Genetic models of tumor formation have been used to explore how combinations of mutations can cooperate to promote neoplasia [5] [6] [7] [8] [9] . Excess epidermal growth factor (EGF) receptor activity is causally linked to many epithelial cancers, including breast cancer [2, 10, 11] . In Drosophila tumor models, EGF receptor (EGFR) overexpression drives hyperplastic growth, but the tissue does not normally progress to neoplasia [12] . When combined with additional genetic alterations, the hyperplastic imaginal disc tissues can undergo neoplastic transformation and metastasis [12] [13] [14] . Interestingly, specific genetic combinations produce tumors with different phenotypic characteristics, suggesting that these models may provide the means to explore specific cancer phenotypes.
A growing body of evidence has suggested an association between altered sugar metabolism and cancer risk [15] [16] [17] [18] . In cancer cells, glucose metabolism shifts away from using pyruvate to feed oxidative phosphorylation toward use of lactate in aerobic glycolysis (the Warburg effect). The lactate dehydrogenase enzyme plays a key role in the shift to Warburg metabolism. Altered metabolism is thought to enhance the growth potential of cancer cells by diverting glucose to produce building blocks for increased biomass in the form of amino acids, at the expense of efficiency in ATP production via the tricarboxylic acid (TCA) cycle [19] . Depletion of lactate dehydrogenase (LDH) can reduce tumorigenesis in EGFR (Neu)-dependent breast cancer as well as c-Myc-mediated transformation [20, 21] , indicating an important role for this metabolic shift. LDH was found to be upregulated in a Drosophila tumor model driven by overexpressing the activated vascular endothelial growth factor (VEGF) or platelet-derived growth factor (PDGF) receptor, Pvr [22] , but its contribution to tumor formation was not assessed. In this report, we identify LDH as a cooperating factor that is both necessary and sufficient for EGFR-driven epithelial neoplasia in vivo. Genetic alterations that increase glucose flux, or a high-sugar diet, were sufficient to promote EGFRdriven neoplasia, and this depends on LDH. These findings provide evidence that Warburg effect metabolism may have a more fundamental role in driving neoplasia than previously appreciated.
RESULTS
In Drosophila imaginal discs, EGFR overexpression drives hyperplastic growth, but the tissue does not progress to neoplasia and metastasis. When combined with depletion of the chromatin regulator pipsqueak (psq), the hyperplastic imaginal disc tissue loses epithelial polarity, undergoes neoplastic transformation, and forms metastases [13] . To examine transcriptional changes during progression from hyperplasia to neoplasia, we examined a time course of progression after transgene induction in wing imaginal discs. At 4 days after transgene induction, both EGFR and EGFR+psq RNAi genotypes produce hyperplastic tissue with overall normal epithelial organization, with normal apicobasal polarity ( Figure 1A ; quantification in Figure S1A ). By 8 days, the EGFR+psq RNAi discs have almost completely lost epithelial organization and continued to grow (Figures 1A and S1A), whereas those expressing EGFR alone have stopped growth and the larvae undergone pupariation.
RNA expression profiles were compared from imaginal discs expressing EGFR with or without the psq RNAi transgene to deplete psq. Samples were collected in quadruplicate at 12 hr 
LDH Activity Required for EGFR-Induced Tumor Formation
(A) Confocal micrographs of wing imaginal discs expressing UAS-EGFR+UAS-GFP alone or together with UAS-psq RNAi to deplete psq. Transgenes were activated using apGal4 and Gal80 ts to control the timing of transgene expression, as described [13] . Discs were labeled with antibody to DE-cadherin (red) to label apical junctional complexes and DAPI (blue) to show the tissue. Samples were collected at 12 hr, 4 days, and 8 days after transgene induction for the EGFR+psq RNAi genotype and at 12 hr and 4 days for EGFR alone. The scale bars represent 100 mm. See Figure S1A for quantification. See Figure S2 for relevant transcript expression data. See Table S1 for list of genes upregulated in neoplasia. See also Figure S3 for lactate measurement.
(B) Unsupervised principal-component analysis illustrating that replicate samples cluster together. PCA shows biological group separation according to time progression (1st component) and genetic background (2nd component; red versus green). The first two components account for 58% of variation in the data. (C) Heatmap illustrating expression levels of the most important genes contributing to the 1st and 2nd PCA components. See Figure S2A for expression data on metabolic pathways. Figure S2B ). We also confirmed that depleting LDH alone had little or no effect on growth of normal tissue ( Figure S1C ). Depletion of LDH reduced tumor growth ( Figures 1D and S1B ) and restored normal epithelial organization in EGFR+psq RNAi tumors, visualized by restored apical localization of the epithelial polarity marker DE-cadherin ( Figure 1D ). We confirmed that elevated LDH expression in these tumors correlated with an increase in lactate production and that depletion of LDH transcript offset this increase ( Figure S3 ). Other transcripts tested had no effect on tumor formation in the EGFR+psq RNAi model (Table S1 ).
Loss of epithelial organization and matrix metalloproteinase 1 (MMP1) expression are typically associated with transformation and invasiveness of human epithelial cancers and correlate with metastatic potential in imaginal disc tumor models [12, 23, 24] . We noted a strong reduction in the amount of MMP1 expression in the LDH depleted tissue, compared to the tissue expressing EGFR+psq RNAi alone ( Figure 1D ). These findings suggest that LDH activity is required for the neoplastic transformation of the epithelial tissue in the EGFR+psq RNAi model. It is noteworthy that depletion of LDH did not affect growth in another epithelial tumor model based on removing scribble, although LDH was upregulated in those tumors [25] .
LDH Drives Neoplasia
A more detailed look at LDH transcript using qPCR showed a progressive increase in LDH levels in tissue expressing EGFR+ psq RNAi . At 4 days, when the tissue was hyperplastic in morphology, the difference was $2-fold ( Figure 2A) . By 8 days, this increased >10-fold, as the tissue became neoplastic (Figure 2A) . The finding that LDH expression was strongly upregulated during the transition from hyperplastic to neoplastic growth prompted us to ask whether LDH might be sufficient to push hyperplastic tissue into neoplasia. To address this, we used an EP line (a P element containing UAS sequences for Gal4 driven activation) inserted at the endogenous ImpL3 gene to allow Gal4-dependent regulation of LDH (overexpression was confirmed by qPCR; Figure S2B ). Although expression of UAS-LDH on its own caused a small reduction in average disc size ( Figures 2B  and S1D ), co-expression of LDH with EGFR led to the formation of large tumors with elevated MMP1 expression compared to the EGFR control ( Figures 2C, 2D , and S1E). The EGFR+LDH tumors also showed loss of epithelial polarity, visualized by loss of polarized DE-cadherin ( Figure 2E ). These tumors also showed disruption of the integrity of the basement membrane, visualized by loss of perlecan expression ( Figure 2F ). Interestingly, co-expression of LDH with the Hippo pathway transcriptional coactivator, Yorkie, or with an activated form of Notch also promoted tumor formation ( Figure S1F ). In each case, the underlying growth driver did not produce neoplasia on its own but can be pushed toward a more aggressive state by increased LDH activity.
Increased Glucose Intake Promotes Neoplasia
Glycolysis is considerably less efficient than oxidative phosphorylation in terms of ATP yield per molecule of glucose. To compensate for this, cancer cells increase glucose uptake by upregulating glucose transporters, including GLUT1 [26, 27] . In this context, it was interesting that Glut1 transcript levels were lower in the neoplastic EGFR+psq
RNAi tumors compared to hyperplastic discs ( Figure S2C ). To test the effect of increased glucose flux, we expressed the EGFR transgene with and without a UAS-Glut1 transgene. Increasing Glut1 expression on its own had only a limited effect on disc size ( Figure S1G ), but when co-expressed with EGFR, Glut1 produced massively overgrown imaginal discs (compare Figure 3A with 3C and 3E with 3F; measurements in Figure S1G ). We observed the same effect by rearing the EGFR-expressing larvae on a high-sugar diet (compare Figure 3A with 3D and 3E with 3H and 3I; measurements in Figure S1H ). Downregulation of Glut1 might reflect a regulatory feedback mechanism designed to limit sugar uptake when the pyruvate shunt is active. This appears to protect against neoplasia. Indeed, further depletion of Glut1 by RNAi treatment strongly reduced growth of the EGFR+psq RNAi tumors ( Figure S1I ). Co-expression of UAS-Glut1 with UAS-EGFR led to loss of epithelial polarity, shown by delocalization of apical DE-cadherin ( Figures 3E and 3F ), but this was largely restored to normal by depleting LDH in this background ( Figure 3G ), and disc size was reduced toward normal ( Figure S1G ). Rearing larvae on a high-sugar diet was not in itself sufficient to compromise epithelial polarity, but when EGFR-expressing larvae were fed high sugar, polarity was lost ( Figures 3H and 3I ). Again, polarity was restored by LDH depletion in the high-sugar model ( Figure 3J ), and disc size was reduced ( Figure S1G ). In both cases, the effects of elevated sugar flux are mediated via LDH activity, suggesting a link to aerobic glycolysis. In a different Drosophila genetic model, a high-sugar diet increased the aggressiveness of tumors produced by expression of oncogenic Ras and activation of Src [28] . In this model, the transformed tissue responds to high sugar by promoting insulin sensitivity. The mechanism appears to be different from the EGFR model in which downregulation of Glut1 appears to form part of a feedback mechanism to limit sugar flux via the pyruvate shunt.
Our findings provide evidence that elevated sugar flux can drive cells toward a neoplastic phenotype. We noted that animals with increased LDH activity, animals with increased Glut1 expression, and those fed with increased dietary sugar contained small patches of GFP-expressing tissue in their body cavity, at some distance from the primary tumorous imaginal disc (boxed regions shown at higher magnification in Figures  3A-3D ). In light of the loss of epithelial organization under these conditions, it is tempting to speculate that these may represent metastatic lesions originating from the primary tumor as a consequence of cellular transformation induced by high levels of aerobic glycolysis.
LDH Promotes a Transformed Phenotype in a Human
Breast Cancer Model A previous study reported that increased GLUT3 expression increased the transformed phenotype in a 3D breast cancer culture model [29] . We asked whether elevated LDH activity was sufficient to promote a transformed phenotype using a breast epithelial cell line derived from normal tissue. HTM3522 cells were transduced to express human LDHA or with a control vector and assayed in culture and in a 3D matrix. In 2D culture, cells overexpressing LDHA become spindle shaped and formed fewer coherent islets ( Figure 4A ). These shape changes are reminiscent of an epithelial-mesenchymal transition. Consistently, LDHA was among the RNAs reported to be upregulated in MCF10A breast cancer cells undergoing epithelial-mesenchymal transition (EMT) [30] . In 3D culture, cells treated with the control vector formed tight acinar spheres, with normal apico-basal polarity (apical inward, visualized by labeling with the Golgi marker GM130; Figures 4B and 4C ). This polarized organization was lost in $1/3 of the samples expressing LDHA ( Figures 4B-4D ). This difference was statistically significant (p = 0.0158; odds ratio 2.07 using Fisher's exact test).
Interestingly, increased glucose transporter levels have been reported to promote a transformed phenotype, reducing epithelial polarization in 3D cultures of breast cancer cells, and these phenotypes were suppressed by lowering glucose transporter levels [29] . Together with our findings, this study prompted us to ask whether increased sugar flux through the glycolytic pathway might be linked to poor clinical outcome in human cancers.
Synergy between LDHA and EGFR in Human Cancer
To examine links between LDH and EGFR in human cancers, we made use of publically available data from The Cancer Genome Atlas (TCGA). 20 cancer types had RNA sequencing data available for at least 100 patients and sufficient clinical follow-up to reveal disease progression in at least 10% of patients. These cancers were selected for analysis (patient information is summarized in Table S2 ). Human LDH enzymes are encoded by 4 genes. The LDHA isoform favors conversion of pyruvate to lactate, whereas LDHB favors conversion of lactate to pyruvate. LDHA expression is elevated in many cancers due to hypoxiainduced upregulation, and LDHB is often downregulated [31] . We therefore determined the ratio of LDHA/LDHB expression for each cancer type and divided the patient populations into 3 equal-sized groups (low, middle, and high). Next, we estimated EGFR activity in these cancers using TCGA protein expression data for total EGFR plus the pY1068 and pY1173 tyrosine phosphorylated forms of EGFR and divided the patients in groups based on EGFR level. Where patient numbers were insufficient for 3 groups, low versus high groups were used, as indicated in Table S2 .
To test the hypothesis that there might be synergy between a shift toward high LDHA/B ratio and elevated EGFR activity, we performed a multivariate regression analysis and calculated the hazard ratio (HR) for synergistic effects progression. Figure 5A ), there was a significant effect on progression-free survival, as indicated by the increased HR. For these three cancer types, we plotted an effect size for LDHA/B ratio, EGFR levels, and the combined effects separately (Figures 5B-5D ). For all 3 cancer types, the patient subgroup with both high EGFR levels and high LDHA/B ratio showed an increased HR, and those with middle or low levels did not (Figures 5B-5D ). For LGG, high EGFR and high LDHA/B ratio had no effect on their own. Interestingly, for sarcoma, the high EGFR group on its own showed a reduced hazard ratio but clearly synergized with high LDHA/B ratio to result in a worse outcome ( Figure 5C ). The breast cancer patients were placed into two groups due to the lower number of hormone-receptor-negative patients with clinical events. Notably, the high LDHA/B group on its own showed a reduced hazard ratio but clearly synergized with high EGFR to result in a worse outcome ( Figure 5D ). These findings provide evidence that patients with both higher LDHA activity and higher EGFR activity show earlier disease progression in breast cancer, sarcoma, and lower grade gliomas.
DISCUSSION
In this report, we identify the LDH enzyme as a critical factor driving the transition from benign hyperplastic growth to neoplasia and metastasis in an EGFR-dependent Drosophila epithelial tumor model. LDH upregulation was needed for EGFR-dependent neoplasia. Moreover, LDH overexpression was sufficient to drive neoplasia in combination with EGFR expression. Overexpression of LDHA in a human primary breast cancer cell model promoted a more transformed cellular phenotype. The possible significance of synergy between high LDH in a background of high EGFR activity in human cancer is supported by our analysis of TCGA datasets: we report evidence that patients with higher LDHA activity and higher EGFR activity show earlier disease progression in breast cancer, sarcoma, and lower grade gliomas. These effects were only seen when the two factors occurred together, suggesting synergy between EGFR activity and the metabolic shift toward aerobic glycolysis.
While this manuscript was in preparation, another study reported that increases in LDHA were able to promote EMT and invasiveness in renal clear cell carcinoma (ccRCC) and that blocking LDH activity could suppress these phenotypes as well as metastasis of ccRCC in xenografts [32] . Although we find no evidence for an effect of LDHA alone or of LDHA/EGFR synergy in the TCGA ccRCC data, these findings merit further attention.
The observations reported here provide evidence that increased sugar flux, whether dietary or due to increased absorption, can promote neoplastic transformation of EGFR-expressing epithelial tissue. The underlying metabolic changes appear to elicit these effects via the lactate shunt, because the effects of high sugar were abrogated by lowering the level of LDH expression in the tissue. A number of recent studies have begun to link elevated sugar flux to the metastatic phenotype [29, 32] . Together with our findings, these studies may provide a molecular framework to better understand the links between diet, obesity, and cancer [16] [17] [18] and may help to select patient populations who might benefit from future therapeutic agents targeting lactate dehydrogenase activity.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Vertical line, reference line; x axis, log 2 hazard ratio and confidence interval; y axis, abbreviation for TCGA cancer type. Data were adjusted for histopathological parameters as indicated in Table S2 .
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STAR+METHODS KEY RESOURCES TABLE

EP-LDH: y[1] w[67c23]; P{w[+mC] y[+mDint2] = EPgy2}EY07426
Bloomington Drosophila Stock Center BDSC: 16829, FlyBase: FBst0016829 
UAS-psq
(D) Control corresponds to ap-Gal4, UAS-CD8-GFP/+; tub-Gal80ts/+; EP-LDH corresponds to ap-Gal4, UAS-CD8-GFP/+; tubGal80ts/EP-LDH (E) Control corresponds to ap-Gal4, UAS-CD8-GFP/+; tub-Gal80ts/+; EGFR corresponds to ap-Gal4, UAS-CD8-GFP/+; UAS-EGFR, tub-Gal80ts/+; EGFR + LDH corresponds to ap-Gal4, UAS-CD8-GFP/+; UAS-EGFR, tub-Gal80ts/EP-LDH
UAS-EGFR, tub-Gal80ts/+; RFP corresponds to ap-Gal4, UAS-CD8-GFP/+; tub-Gal80ts/UAS-RFP; EP-LDH corresponds to apGal4, UAS-CD8-GFP/+; tub-Gal80ts/EP-LDH; EP-LDH + LDHi corresponds to ap-Gal4, UAS-CD8-GFP/UAS-LDH
RNAi ; tubGal80ts/EP-LDH; EGFR corresponds to ap-Gal4, UAS-CD8-GFP/+; UAS-EGFR, tub-Gal80ts/+; EGFR + Psq-RNAi corresponds to ap-Gal4, UAS-psq RNAi /UAS-CD8-GFP; UAS-EGFR, tub-Gal80ts/+; and control corresponds to ap-Gal4, UAS-CD8-GFP/+;
tub-Gal80ts/+ Figure S3 EGFR The Gal4/Gal80 system was used to allow conditional transgene activation in order to bypass early lethality due to expression of EGFR+psq RNAi . Embryos were collected for 24h (for microarray experiments) or 48h (for immunostaining) at 18 C and were allowed to develop at 18 C to maintain Gal80-dependent repression of Gal4 until the larvae reached early third instar (5 days for immunostaining or 7 days for microarray experiments). Larvae were then transferred to 29 C to induce Gal4 and raised for the indicated times. Larval gender was not considered.
Cell lines
HTM3522 breast epithelial cells (female) were cultured in H14 medium consisting of DMEM:F12 with 2 mM glutamine containing 250ng/mL insulin, 10ng/mL EGF, 10mg/mL transferrin, 2.6ng/mL sodium selenite, 10 À10 M estradiol, 1.4x10 6 M hydrocortisone and 5mg/mL prolactin as described [42] .
Phoenix-Ampho cells were purchased from American Type Culture Collection. These were not further authenticated.
METHOD DETAILS
RNA extraction and microarrays
Approximately 20 pairs of wing discs were dissected and processed for total RNA extraction using Trizol (Life Technologies). RNA was prepared from dissected imaginal discs from four replicates of each of the five conditions: EGFR and EGFR+psq RNAi at 12 hr;
EGFR and EGFR+psq RNAi samples at day 4, and from EGFR+psq RNAi at day 11 of tumor growth. Expression profiling was performed with Genechip Drosophila Genome 1.0 Arrays (Affymetrix) by the Genomics Core Facility at European Molecular Biology Laboratory (Heidelberg, Germany). Samples were blinded to the Genomics Core Facility for profiling.
Microarray data analysis
Microarray data analysis was performed using R(3.4.3)/Bioconductor [37] . Robust Multi-array Average (RMA) algorithm [43, 44] was used to normalize variation between arrays and within probe sets and to improve data distribution by log2 transformation of intensity values as implemented in oligo (1.42.0) package in Bioconductor R (http://www.bioconductor.org/packages/release/bioc/html/ oligo.html [38],). For downstream analysis control, background and spike-in probes were removed. As well as genes whose expression was below background detection threshold in at least 4 samples. Threshold was defined as 80% of anti-genomic (background hybridization) probe intensity's. This is important since expression estimate may not be a reliable for these genes. To ask if the gene expression data separated samples according to biological groups, principal component analysis (PCA) was applied to scaled log 2 data. We used the ''FactoMineR'' (1.40) package with default options [[39] ]. Genes that exhibited variation in expression levels between time points or genetic groups were selected for PCA analysis (based on linear model fit; adj.p.val < 0.05)(Limma; 3.34. 9 [40] ). This removes non-informative signals. Genes that contributed to first (time) and second (groups) component (> 0.025) were selected and their expression levels were visualized as a heatmap. Data was scaled and centered relative to control samples. Genes differentially expressed in 4d versus 11d EGFR+psq RNAi tumors were identified using ''Limma'' package with default settings. A gene was considered differentially expressed when the Bonferroni corrected P value was < 0.05 and the log 2 fold change > 1.5. Metabolic pathway status was assessed by examining gene signatures associated with KEGG maps; Glycolysis/Gluconeogenesis (above phosphoenolpyruvate); TCA cycle; Fructose and mannose metabolism; Oxidative phosphorylation (first 4 complexes); Pyruvate metabolism; Fatty acid biosynthesis; Fatty acid degradation. Normalized gene expression data was scaled and centered relative to control samples.
Quantitative PCR 20 wing imaginal discs from 3 rd instar larvae were dissected in ice-cold PBS and were incubated in 1000 ml TRIzol (Invitrogen) for 5 min at room temperature. After the addition of 200 ml Chloroform, samples were vortexed vigorously for at least 15 s and incubated at room temperature for 3 min. The sample was centrifuged at 12000 g for 15 minutes at 4 C. Following centrifugation, the mixture separated into lower red, the phenol-chloroform phase, an interphase, and a colorless upper aqueous phase. RNA remains exclusively in the aqueous phase. The upper aqueous phase ($350 ml) was carefully transferred into fresh tube without disturbing the interphase. The RNA was precipitated from the aqueous phase by mixing it with 500 ml isopropyl alcohol. After 10 min incubation at room temperature, the sample was centrifuged at 12000 g for 10 min at 4 C. The RNA precipitate, often invisible before centrifugation, forms a gel-like pellet on the bottom of the tube. The pellet is washed with 1ml 75% ethanol. After centrifugation (7500 g, 5 min, 4 C), supernatant is removed completely and the pellet is air-dried for 5-10 min. RNA is resuspended in 30 ml sterile water. Up to 3 mg total RNA was treated with RQ1 DNase I (Promega) and reverse-transcribed using the SuperScriptÒ III Reverse Transcriptase Kit and oligo(dT) Primer. For RNA denaturation, 1 ml of the primers, 1 ml 10mM dNTPs and the DNase-treated RNA were first incubated in a reaction volume of 13 ml for 5 min at 65 C and cooled down on ice. Next, 4 ml 5x First-Strand Buffer, 1 ml 0.1 M DTT, 1 ml of RNaseOUT RNase Inhibitor and 1 ml Superscript III RT (200 units/ml) were added. The reaction mix was incubated at 50 C for 60 min and inactivated at 70 C for 10 min. Real-time quantification was performed using SsoFastTM EvaGreen reagents (BioRad) on QuantStudio 6 Flex Real-Time PCR System (Applied Biosystem). Primer Sequences: aTub84B forward: TGGGCCCGTCTGGACCACAA aTub84B reverse: TCGCCGTCACCGGAGTCCAT LDH forward: GCTGGTAGAGTACAGTCCCG LDH reverse: GGACGAGTCCAAGTTGGTG Glut1 forward: ACCGATTGGCTAACTGCATC Glut1 reverse: CAGACAGGTGGAGGCTGAC Samples were not blinded. No data were excluded.
Immunostaining
Primary antibodies: rabbit anti-Perlecan (provided by Stefan Baumgartner [33]); anti-DE-Cadherin, and mouse anti-MMP1 (3A6B4/ 5H7B11/3B8D12 antibodies were mixed in equal amounts) were from Developmental Studies Hybridoma Bank. Alexa Fluor 635 phalloidin was used to label F-actin (Life Technologies). Third-instar larvae were dissected in PBS and fixed in 4% formaldehyde/PBS for 20' RT then washed three times for 10' in 0.1%Triton/PBS (PBT) and blocked for 30' in 3% BSA in PBT, 5mM NaCl (BBT). Samples were incubated at 4 C overnight with primary antibody diluted in BBT, washed three times for 15' in BBT, and incubated with fluorescent secondary antibody and DAPI for 1h RT. After four 15' washes with PBT, discs were mounted in 90% glycerol and PBS containing 0.05% N-Propyl Gallate. Samples were not randomized or blinded. Key experiments were repeated several times by 2 investigators with independent crosses over a period of years with consistent results. Samples were not blinded. For quantification, at least 10 larvae were dissected and analyzed as described below.
LDHA expression, cell culture, viral transduction The LDHA-expressing construct was cloned by PCR using cDNA from HMT3522 cells into the pBabe (puro) expression vector with the primers ATGCAGATCTAATATGGCAACTCTAAAGGATC and GCGAGTCGACTTAAAATTGCAGCTCCTTTTGG. The plasmid was sequenced to verify the ORF (NM_005566). Phoenix-Ampho cells were cultured in DMEM media. Amphotropic retroviruses were made as described previously [45] . Viral particles-containing supernatant from transfected Phoenix-Ampho cells was harvested at 36-48 hr. HMT3522 cells were plated in H14 media 24 hours before being infected with viruses expressing LDHA or control empty vector overnight in the presence of 8 mg/ml polybrene. Puromycin (1mg/ml) selection was started at 36 hours and stable cells were obtained after 3 days. size all groups were treated as ordered factors and adjusted for classical histopathology parameters as indicated in Table S2 . Patients with complete information on time to an event, status, histopathology parameters used for adjustment, LDHA/LDHB expression levels and EGFR protein levels were included in the regression analysis. A linear Cox proportion hazard regression model with ''contr. poly'' contrast was used to calculate interaction hazard ratio and p value. Contrast was set to ''contr.treatment'' in order to visualize the effect size for increase in overall EGFR level and increase in LDHA shift separately and for their interaction. Statistical analyses were performed using R Software and results were visualized as forest plots using GraphPad Prism.
DATA AND SOFTWARE AVAILABILITY
The accession number for the microarray data reported in this paper is GEO: GSE95613.
